Jasper Therapeutics, Inc., (JSPR): Price and Financial Metrics
JSPR Price/Volume Stats
| Current price | $5.28 | 52-week high | $31.01 |
| Prev. close | $5.37 | 52-week low | $4.55 |
| Day low | $5.04 | Volume | 247,100 |
| Day high | $5.40 | Avg. volume | 668,793 |
| 50-day MA | $8.63 | Dividend yield | N/A |
| 200-day MA | $17.85 | Market Cap | 79.32M |
JSPR Stock Price Chart Interactive Chart >
Jasper Therapeutics, Inc., (JSPR) Company Bio
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR Price Returns
| 1-mo | -14.01% |
| 3-mo | -76.50% |
| 6-mo | -75.41% |
| 1-year | -80.09% |
| 3-year | -84.42% |
| 5-year | -94.56% |
| YTD | -75.30% |
| 2024 | 170.98% |
| 2023 | 63.39% |
| 2022 | -93.85% |
| 2021 | -21.58% |
| 2020 | N/A |
Loading social stream, please wait...